Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 6, 1999, Pages 2002-2007

  Johansson, A G ^a   Engstrom, B E ^a   Ljunghall, S ^a   Karlsson, F A ^a   Burman, P ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0033305346     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.6.2002     Document Type: Article

References (45)

1. Regulation by growth hormone of number of chondrocytes containing IGF-I in rat growth plate
2. The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I
3. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset
4. Reduced bone mineral density in patients with adult onset growth hormone deficiency
5. Reduced bone mineral content in adult patients with growth hormone deficiency
6. Low bone mineral density in adults with previous hypothalamic-pituitary tumors: Correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3
7. Consequences of childhood-onset growth hormone deficiency for adult bone mass
8. Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism
9. Increased prevalence of osteoporosis and arteriosclerosis in patients with conventionally substituted pituitary insufficiency: Is there a need for additional growth hormone substitution?
10. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency
11. Serum osteocalcin and bone isoenzyme alkaline phosphatase in growth hormone-deficient patients: Dose-response studies with biosynthetic human GH
12. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition
13. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism
14. Effects of physiological growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency
15. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males
16. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects
17. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: A double blind, randomized, placebo-controlled study
18. Effect of growth hormone replacement on bone mass in adult onset growth hormone deficiency
19. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency
20. Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: Results of a double-blind placebo-controlled study with open follow-up
21. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women
22. Growth hormone substitution in adult growth hormone deficient men augments androgen effects on the skin
23. Anabolic and androgenic effect of testosterone in sexually immature boys and its dependency on growth hormone
24. Contrasting effects of oral and transdermal routes of replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor 1, and GH-binding protein in postmenopausal women
25. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women
26. Estradiol treatment of acromegaly: Reduction of immunoreactive somatomedin C and improvement of metabolic status
27. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations
28. An amplitude-specific divergence in the pulsatile mode of growth hormone secretion underlies the gender difference in mean GH concentration in men and premenopausal women
29. Gender differences in secretory activity of the human somatropic (growth hormone) axis
30. Developmental changes and differential regulation by testosterone and estradiol of growth hormone receptor expression in the rabbit
31. Growth hormone binding proteins in the rat: Effects of gonadal steroids
32. Effect of testosterone on insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the hypophysectomized rat
33. Bone marrow, cytokines, and bone remodeling
34. Estrogen enhances growth hormone receptor expression and growth hormone action in rat osteosarcoma cells and human osteoblast-like cells
35. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency
36. Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults
37. Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset
38. The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men
39. Growth hormone stimulates bone formation and strength of cortical bone in aged rats
40. The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged rats
41. Reduced bone mineral density in adults with growth hormone (GH) deficiency: Increased bone turnover during 12 months of GH substitution therapy
42. The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults
43. The effect of low dose recombinant human growth hormone replacement on indices of bone remodelling and bone mineral density in hypopituitary growth hormone-deficient adults
44. Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency
45. Bone mineral density reflects bone mass but also the degree of mineralization of bone: Therapeutic implications